Taiwan FDA registration 5f7c3746d92b63ab469904a8944a1e0d
Coronary angioplasty guide line
TW: 冠狀動脈血管造型術引導線
Taiwan·USCI DIVISION C.R. BARD, INC.·Registered Oct 28, 1992 – Oct 28, 1997CancelledRegistration details
- Analysis ID
- 5f7c3746d92b63ab469904a8944a1e0d
- Customs Code
- DHA00600679605
Company information
- Manufacturer
- USCI DIVISION C.R. BARD, INC.
- Manufacturer Country
- United States
- Authorized Representative
- SEAN K. FU & CO., LTD.
Product details
- Product Type (Level 1)
- 0699 Other Intensive Care Unit & Cardiac Care Unit Equipment
- Import Information
- import
Dates and status
- Registration Date
- Oct 28, 1992
- Expiry Date
- Oct 28, 1997
- Cancellation Date
- Nov 17, 2004
Cancellation information
- Status
- Logged out
- Reason
- 未展延而逾期者
About this record
Access comprehensive regulatory information for Coronary angioplasty guide line in Taiwan's medical device market through Pure Global AI's free database. is registered under number 5f7c3746d92b63ab469904a8944a1e0d and manufactured by USCI DIVISION C.R. BARD, INC.. The authorized representative in Taiwan is SEAN K. FU & CO., LTD..
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices